175 related articles for article (PubMed ID: 3008669)
1. [Evaluation of postoperative immunochemotherapy in lung cancer].
Ikeda T; Sakai T; Suito T; Kosaki G
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1044-9. PubMed ID: 3008669
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
3. [Effect of concomitant use of immunomodulator (OK-432 and/or PSK) on advanced lung cancer (squamous cell carcinoma and adenocarcinoma) treated with radiation with combined chemotherapy].
Ogawa Y; Kimura S; Imajo Y; Hiratsuka J; Ichiyanagi A; Ashida C; Oshitani T; Imanaka K; Obayashi K; Takada Y
Rinsho Hoshasen; 1982 Dec; 27(13):1445-8. PubMed ID: 7166858
[No Abstract] [Full Text] [Related]
4. [Evaluation of postoperative immunochemotherapy of lung cancer].
Ikeda T; Sakai T; Suito T; Kosaki G
Nihon Kyobu Geka Gakkai Zasshi; 1987 Jan; 35(1):1-4. PubMed ID: 3572111
[No Abstract] [Full Text] [Related]
5. [Studies on long-term intermittent immunochemotherapy of lung cancer--with special reference to surgical cases].
Fukami A
Igaku Kenkyu; 1984 Apr; 54(4):383-400. PubMed ID: 6099675
[No Abstract] [Full Text] [Related]
6. A randomized trial of postoperative CDDP-based chemotherapy/chemoradiotherapy vs short-term immunochemotherapy in lung cancer.
Sagawa M; Sato M; Fujimura S; Usuda K; Kondo T; Tanita T; Takahashi S; Ono S; Matsumura Y; Handa M; Saito Y
J Cardiovasc Surg (Torino); 2000 Dec; 41(6):935-9. PubMed ID: 11232980
[TBL] [Abstract][Full Text] [Related]
7. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Fujisawa T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
Watanabe Y; Iwa T
J Biol Response Mod; 1987 Apr; 6(2):169-80. PubMed ID: 3585412
[TBL] [Abstract][Full Text] [Related]
9. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Fujisawa T; Yamaguchi Y
Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
[TBL] [Abstract][Full Text] [Related]
10. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432].
Nakarai I; Rikitake H; Koga T; Hayashi A; Harada Y; Takamoto M; Ishibashi T; Shinoda A; Sagawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3050-7. PubMed ID: 2823723
[TBL] [Abstract][Full Text] [Related]
11. [Surgery and adjuvant therapy of non-small cell lung cancer].
Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432.
Watanabe Y; Iwa T
Cancer; 1984 Jan; 53(2):248-53. PubMed ID: 6690008
[TBL] [Abstract][Full Text] [Related]
13. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
Imaizumi M; Kondo T; Kamei H; Ichihashi H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.
Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y;
J Immunother; 2001; 24(3):250-6. PubMed ID: 11394503
[TBL] [Abstract][Full Text] [Related]
15. [Pathological variability and cancer treatment in lung cancer].
Kodama T
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
[TBL] [Abstract][Full Text] [Related]
16. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
[TBL] [Abstract][Full Text] [Related]
17. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of concomitant use of non-specific immunopotentiator on 172 cases of primary lung cancer (stage III, IV) treated with radiation combined with chemotherapy (author's transl)].
Ogawa Y; Kimura S; Imajo Y; Hamada F; Miyaji C; Imanaka K; Takashima H; Ohbayashi K; Takada Y
Rinsho Hoshasen; 1982 Apr; 27(4):451-4. PubMed ID: 7109272
[No Abstract] [Full Text] [Related]
19. [Evaluation of immunochemotherapy in patients with primary liver cancer. Osaka Research Society for Liver, Gallbladder and Pancreas].
Kojima J; Kamata T; Monna T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):179-87. PubMed ID: 3099651
[TBL] [Abstract][Full Text] [Related]
20. [Immunochemotherapy of resectable lung cancer--a preliminary study on a comparison of the control, levamisole, and OK-432].
Okayasu T; Kashimura Y; Matano J; Kawabata M; Takeoka T; Hashimoto M; Tanabe T
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1646-52. PubMed ID: 6764120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
